• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Citigroup, Bank of America And 48 Stocks Moving In Friday's Mid-Day Session

    7/15/22 12:11:01 PM ET
    $ADVM
    $ALRN
    $AOUT
    $AREB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ADVM alert in real time by email

    Gainers

    • United Maritime Corporation (NASDAQ:USEA) shares jumped 180.9% to $6.19. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering on Wednesday.
    • Cemtrex, Inc. (NASDAQ:CETX) gained 52.8% to $0.4759 after gaining over 5% on Thursday.
    • Nymox Pharmaceutical Corporation (NASDAQ:NYMX) rose 43.5% to $0.3101 after declining over 36% on Thursday. NYMOX received deficiency letter from NASDAQ.
    • ITHAX Acquisition Corp. (NASDAQ:ITHX) surged 34.7% to $13.41.
    • NexImmune, Inc. (NASDAQ:NEXI) jumped 29.9% to $1.9099 after the company received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for its first cellular therapy product candidate NEXI-003 addressing solid tumors..
    • ToughBuilt Industries, Inc. (NASDAQ:TBLT) gained 21% to $2.8899 after gaining 10% on Thursday. ToughBuilt Industries recently announced its Q2 gross sales through Amazon were $3.56 million, representing a 20% year-over-year increase.
    • Greenbrook TMS Inc. (NASDAQ:GBNH) rose 19.7% to $1.6999.
    • Vertical Aerospace Ltd. (NYSE:EVTL) shares gained 19.3% to $3.46 after the company announced FLYINGGROUP has conditionally pre-ordered up to 50 VX4 aircrafts.
    • Sonim Technologies, Inc. (NASDAQ:SONM) rose 18.1% to $0.6969. Sonim Technologies CEO Peter Liu Hao reported the purchase of 952,381 shares at an average price of $0.84 per share.
    • American Rebel Holdings, Inc. (NASDAQ:AREB) gained 16.6% to $1.0381.
    • 180 Life Sciences Corp. (NASDAQ:ATNF) surged 15.8% to $1.24. 180 Life Sciences, last month, received a written response from the U.K.'s regulatory agency and U.S. FDA related to questions submitted in a Type C meeting request for anti-TNF treatment, adalimumab, to treat early-stage Dupuytren's disease.
    • Lion Group Holding Ltd. (NASDAQ:LGHL) gained 14.5% to $1.50.
    • Pinterest, Inc. (NYSE:PINS) rose 13.3% to $19.90 following a WSJ report suggesting Elliott Management has been in discussions with the company.
    • IsoPlexis Corporation (NASDAQ:ISO) gained 12.7% to $3.37.
    • Sol-Gel Technologies Ltd. (NASDAQ:SLGL) jumped 11.8% to $5.13.
    • Digital Media Solutions, Inc. (NYSE:DMS) gained 11.4% to $1.27.
    • Citigroup Inc. (NYSE:C) gained 10.3% to $48.67 after the company reported better-than-expected Q2 EPS and sales results.
    • OceanPal Inc. (NASDAQ:OP) surged 9.7% to $0.4720.
    • VOXX International Corporation (NASDAQ:VOXX) gained 9.4% to $7.12. VOXX International recently reported worse-than-expected Q1 sales results.
    • Wells Fargo & Company (NYSE:WFC) rose 7.3% to $41.57 after the company reported Q2 earnings.
    • U.S. Bancorp (NYSE:USB) gained 4.9% to $46.43 after the company reported Q2 financial results.
    • Bank of America Corporation (NYSE:BAC) rose 4.8% to $31.58. Shares of banks and financial services companies traded higher as investors assessed this week's earnings report from several notable companies in the sector.
    • UnitedHealth Group Incorporated (NYSE:UNH) rose 4.8% to $526.08 as the company reported Q2 FY22 sales of $80.3 billion, up 13% Y/Y, beating the consensus of $79.68 billion, with double-digit growth at both Optum and UnitedHealthcare.
    • The Bank of New York Mellon Corporation (NYSE:BK) gained 4.8% to $42.38 after the company reported better-than-expected Q2 sales results.
    • The Goldman Sachs Group, Inc. (NYSE:GS) rose 3.9% to $292.53. Goldman Sachs Group is set to give its latest quarterly earnings report on Monday.
    • Morgan Stanley (NYSE:MS) gained 3.8% to $77.56. Shares of banks and financial services companies traded higher as investors assessed this week's earnings report from several notable companies in the sector.


    Losers

    • Codexis, Inc. (NASDAQ:CDXS) shares tumbled 41.9% to $7.01 after the company issued Q2 and FY22 sales guidance below analyst estimates.
    • Synthetic Biologics, Inc. (NYSE:SYN) fell 31.7% to $0.1591 after the company announced a 1-for-10 reverse stock split.
    • First Wave BioPharma, Inc. (NASDAQ:FWBI) dropped 25.3% to $0.1490 after the company announced a private placement.
    • 10x Genomics, Inc. (NASDAQ:TXG) fell 22.8% to $33.42 after the company issued Q2 sales guidance below estimates.
    • Evofem Biosciences, Inc. (NASDAQ:EVFM) dropped 19.5% to $0.8607. Morgan Stanley maintained Evofem Biosciences with an Underweight and lowered the price target from $2 to $0.75.
    • Aileron Therapeutics, Inc. (NASDAQ:ALRN) declined 19.4% to $0.1824. Aileron Therapeutics recently announced interim data from its Phase 1b NSCLC trial of ALRN-6924 and said it plans to stop further enrollment in the NSCLC trial.
    • Harsco Corporation (NYSE:HSC) fell 17.1% to $4.81 after the company updated its expected financial results for Q2 and FY22 outlook. The company expects Q2 U.S. GAAP operating loss from continuing operations of $(95) million - $(97) million (prior view for income of $17 million - $22 million).
    • Sentage Holdings Inc. (NASDAQ:SNTG) fell 16% to $0.5775 after jumping over 20% on Thursday.
    • InMed Pharmaceuticals Inc. (NASDAQ:INM) fell 15.5% to $0.3750. InMed Pharmaceuticals recently received Nasdaq notification regarding minimum bid price compliance.
    • Quhuo Limited (NASDAQ:QH) dipped 14.8% to $0.3013.
    • Plug Power Inc. (NASDAQ:PLUG) fell 14.7% to $15.15.
    • Adverum Biotechnologies, Inc. (NASDAQ:ADVM) dropped 14.6% to $1.4950 as the company announced new data from the OPTIC study of ADVM-022 for wet age-related macular degeneration (wet AMD) during the American Society of Retina Specialists 2022 Annual Meeting.
    • Clever Leaves Holdings Inc. (NASDAQ:CLVR) fell 14.3% to $1.1650.
    • CEL-SCI Corporation (NYSE:CVM) declined 14.3% to $3.8395.
    • Maxeon Solar Technologies, Ltd. (NYSE:MAXN) fell 14% to $10.56.
    • Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) dipped 14% to $9.94.
    • American Outdoor Brands, Inc. (NASDAQ:AOUT) fell 13.6% to $8.14. American Outdoor Brands recently reported a fourth-quarter sales decline of 28.8% year-over-year to $45.89 million, beating the consensus of $45.49 million.
    • Innovative Industrial Properties, Inc. (NYSE:IIPR) dropped 12.8% to $96.95.
    • The Alkaline Water Company Inc. (NASDAQ:WTER) fell 11.6% to $0.4373.
    • Spectrum Brands Holdings, Inc. (NYSE:SPB) dropped 11.6% to $64.35. Raymond James recently initiated coverage on Spectrum Brands with a Market Perform rating.
    • McEwen Mining Inc. (NYSE:MUX) fell 11.3% to $0.3547.
    • Daqo New Energy Corp. (NYSE:DQ) dipped 10.3% to $62.93.
    • XORTX Therapeutics Inc. (NASDAQ:XRTX) fell 8.1% to $ 1.6910. XORTX recently announced topline results from Part 1 of the 3 part Pharmacokinetics Bridging Study showed a substantial increase in oral bioavailability of two versions of its proprietary oxypurinol formulation.
    • TDH Holdings, Inc. (NASDAQ:PETZ) fell 6.5% to $2.7950. TDH Holdings announced on Tuesday the withdrawal of its registration statement. The company will not proceed with its proposed offering.
    Get the next $ADVM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADVM
    $ALRN
    $AOUT
    $AREB

    CompanyDatePrice TargetRatingAnalyst
    UnitedHealth Group Incorporated
    $UNH
    4/7/2026$300.00Reduce → Hold
    HSBC Securities
    Morgan Stanley
    $MS
    4/7/2026$196.00Neutral → Buy
    UBS
    Pinterest Inc.
    $PINS
    4/7/2026$27.00 → $25.00Overweight
    Wells Fargo
    Wells Fargo & Company
    $WFC
    4/1/2026$94.00Hold → Buy
    HSBC Securities
    UnitedHealth Group Incorporated
    $UNH
    4/1/2026$330.00Mkt Perform → Outperform
    Raymond James
    Bank of America Corporation
    $BAC
    4/1/2026$57.00Hold → Buy
    HSBC Securities
    10x Genomics Inc.
    $TXG
    3/31/2026Mkt Perform → Outperform
    William Blair
    U.S. Bancorp
    $USB
    3/26/2026$55.00Hold
    Jefferies
    More analyst ratings

    $ADVM
    $ALRN
    $AOUT
    $AREB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Tang Kevin bought $12,688,806 worth of shares (900,000 units at $14.10) (SEC Form 4)

    4 - Aurinia Pharmaceuticals Inc. (0001600620) (Issuer)

    3/3/26 5:35:12 PM ET
    $AUPH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Opaleye Management Inc. bought $18,333 worth of Ordinary Shares (291 units at $63.00) (SEC Form 4)

    4 - Sol-Gel Technologies Ltd. (0001684693) (Issuer)

    2/18/26 4:05:16 PM ET
    $SLGL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: Large owner Opaleye Management Inc. bought $5,800 worth of Ordinary Shares (100 units at $58.00) (SEC Form 4)

    4/A - Sol-Gel Technologies Ltd. (0001684693) (Issuer)

    2/18/26 12:59:29 PM ET
    $SLGL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADVM
    $ALRN
    $AOUT
    $AREB
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for TWYNEO issued to SOL-GEL TECHNOLOGIES LTD

    Submission status for SOL-GEL TECHNOLOGIES LTD's drug TWYNEO (ORIG-1) with active ingredient TRETINOIN;BENZOYL PEROXIDE has changed to 'Approval' on 07/26/2021. Application Category: NDA, Application Number: 214902, Application Classification: Type 4 - New Combination

    7/27/21 10:39:03 AM ET
    $SLGL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for LUPKYNIS

    Submission status for AURINIA PHARMACEUTICALS, INC.'s drug LUPKYNIS (ORIG-1) with active ingredient VOCLOSPORIN has changed to 'Approval' on 01/22/2021. Application Category: NDA, Application Number: 213716, Application Classification: Type 1 - New Molecular Entity

    1/25/21 11:31:10 AM ET
    $AUPH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADVM
    $ALRN
    $AOUT
    $AREB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Hrt Financial Lp

    4 - Lion Group Holding Ltd (0001806524) (Issuer)

    4/13/26 10:17:24 AM ET
    $LGHL
    Investment Bankers/Brokers/Service
    Finance

    SEC Form 3 filed by new insider Wang Cheng Kevin

    3 - Maxeon Solar Technologies, Ltd. (0001796898) (Issuer)

    4/13/26 6:04:27 AM ET
    $MAXN
    Semiconductors
    Technology

    SEC Form 3 filed by new insider Zhou Bin I

    3 - Maxeon Solar Technologies, Ltd. (0001796898) (Issuer)

    4/13/26 6:02:49 AM ET
    $MAXN
    Semiconductors
    Technology

    $ADVM
    $ALRN
    $AOUT
    $AREB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    UnitedHealth upgraded by HSBC Securities with a new price target

    HSBC Securities upgraded UnitedHealth from Reduce to Hold and set a new price target of $300.00

    4/7/26 8:51:26 AM ET
    $UNH
    Medical Specialities
    Health Care

    Morgan Stanley upgraded by UBS with a new price target

    UBS upgraded Morgan Stanley from Neutral to Buy and set a new price target of $196.00

    4/7/26 8:36:03 AM ET
    $MS
    Investment Bankers/Brokers/Service
    Finance

    Wells Fargo resumed coverage on Pinterest with a new price target

    Wells Fargo resumed coverage of Pinterest with a rating of Overweight and set a new price target of $25.00 from $27.00 previously

    4/7/26 8:11:14 AM ET
    $PINS
    Computer Software: Programming Data Processing
    Technology

    $ADVM
    $ALRN
    $AOUT
    $AREB
    SEC Filings

    View All

    SEC Form FWP filed by Goldman Sachs Group Inc.

    FWP - GOLDMAN SACHS GROUP INC (0000886982) (Subject)

    4/13/26 5:24:47 PM ET
    $GS
    Investment Bankers/Brokers/Service
    Finance

    SEC Form FWP filed by Bank of America Corporation

    FWP - BANK OF AMERICA CORP /DE/ (0000070858) (Subject)

    4/13/26 5:18:44 PM ET
    $BAC
    Major Banks
    Finance

    SEC Form FWP filed by Citigroup Inc.

    FWP - CITIGROUP INC (0000831001) (Subject)

    4/13/26 4:04:37 PM ET
    $C
    Major Banks
    Finance

    $ADVM
    $ALRN
    $AOUT
    $AREB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset

    • VB4-P5 – novel new chemical entity with potential to address significant unmet need in rare and large-market chronic kidney disease • CALGARY, Alberta, April 13, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU)), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease, is pleased to announce the closing of the acquisition of the Vectus kidney anti-fibrotic asset (the "Acquisition"). The Company announced that it entered a binding term sheet on October 17, 2025 to acquire a Renal Anti-Fibrotic Therapeutic Program (the "Program") from Vectus Bios

    4/13/26 5:00:00 PM ET
    $XRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Pinterest to Announce First Quarter 2026 Results

    Pinterest, Inc. (NYSE:PINS) will release financial results for the first quarter 2026 on Monday, May 4th, 2026 after market close. The company will host its quarterly conference call to discuss these results at 1:30 p.m. PT (4:30 p.m. ET) on the same day. A live webcast of the conference call and related earnings release materials can be accessed on Pinterest's Investor Relations website at investor.pinterest.com. A replay of the webcast will be available through the same link following the conference call. Disclosure Information Pinterest uses and intends to continue to use its Investor Relations website as a means of disclosing material nonpublic information and for complying with i

    4/13/26 4:06:00 PM ET
    $PINS
    Computer Software: Programming Data Processing
    Technology

    BofA Names Olena Lifset Oklahoma City President

    Tony Shinn Retires After 20 Years with CompanyOKLAHOMA CITY, April 13, 2026 /PRNewswire/ -- Bank of America today announced that Olena Lifset, Global Commercial Banking market executive, will become its new Oklahoma City president. She succeeds Tony Shinn, who successfully led the market since 2008, and is retiring after 20 years with the company. As president and head of the market, Lifset will connect clients, teammates and communities to the full power of the franchise and drive collaboration across the company's eight lines of business. She will oversee Bank of America's eff

    4/13/26 9:00:00 AM ET
    $BAC
    Major Banks
    Finance

    $ADVM
    $ALRN
    $AOUT
    $AREB
    Financials

    Live finance-specific insights

    View All

    Pinterest to Announce First Quarter 2026 Results

    Pinterest, Inc. (NYSE:PINS) will release financial results for the first quarter 2026 on Monday, May 4th, 2026 after market close. The company will host its quarterly conference call to discuss these results at 1:30 p.m. PT (4:30 p.m. ET) on the same day. A live webcast of the conference call and related earnings release materials can be accessed on Pinterest's Investor Relations website at investor.pinterest.com. A replay of the webcast will be available through the same link following the conference call. Disclosure Information Pinterest uses and intends to continue to use its Investor Relations website as a means of disclosing material nonpublic information and for complying with i

    4/13/26 4:06:00 PM ET
    $PINS
    Computer Software: Programming Data Processing
    Technology

    BofA Names Olena Lifset Oklahoma City President

    Tony Shinn Retires After 20 Years with CompanyOKLAHOMA CITY, April 13, 2026 /PRNewswire/ -- Bank of America today announced that Olena Lifset, Global Commercial Banking market executive, will become its new Oklahoma City president. She succeeds Tony Shinn, who successfully led the market since 2008, and is retiring after 20 years with the company. As president and head of the market, Lifset will connect clients, teammates and communities to the full power of the franchise and drive collaboration across the company's eight lines of business. She will oversee Bank of America's eff

    4/13/26 9:00:00 AM ET
    $BAC
    Major Banks
    Finance

    341 Merrill Advisors Recognized on the 2026 Barron's "Top 1,500 Financial Advisors" List. Published on March 20, 2026. Ranking based on data as of September 30, 2025.

    Barron's named 9 Merrill Advisors No. 1 in their stateKey Points:341 Merrill advisors recognized on the 2026 Barron's Top 1,500 Financial Advisors list.Nine Merrill advisors ranked No. 1 in their state.NEW YORK, April 9, 2026 /PRNewswire/ --Barron's recognized 341 Merrill Wealth Management and Merrill Private Wealth Advisors on its annual Top 1,500 Financial Advisors List (Published on March 20, 2026. Ranking based on data as of September 30, 2025). Merrill also had 9 advisors named No. 1 in the state. This high-level representation speaks directly to the quality of Merrill's talent and their dedication to serving client needs.

    4/9/26 9:30:00 AM ET
    $BAC
    Major Banks
    Finance

    $ADVM
    $ALRN
    $AOUT
    $AREB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Citigroup Inc.

    SC 13D - CITIGROUP INC (0000831001) ()

    1/5/94 12:00:00 AM ET
    $C
    Major Banks
    Finance

    Amendment: SEC Form SC 13D/A filed by Bank of America Corporation

    SC 13D/A - BANK OF AMERICA CORP /DE/ (0000070858) (Filed by)

    12/13/24 4:29:10 PM ET
    $BAC
    Major Banks
    Finance

    Amendment: SEC Form SC 13G/A filed by Pinterest Inc.

    SC 13G/A - PINTEREST, INC. (0001506293) (Subject)

    12/6/24 10:11:26 AM ET
    $PINS
    Computer Software: Programming Data Processing
    Technology

    $ADVM
    $ALRN
    $AOUT
    $AREB
    Leadership Updates

    Live Leadership Updates

    View All

    Morgan Stanley Investment Management Enters Digital Investments Universe With Launch of Morgan Stanley Bitcoin Trust

    Morgan Stanley Investment Management (MSIM) announced today the launch of Morgan Stanley Bitcoin Trust (NYSE:MSBT), an exchange-traded product (ETP) that seeks to track the performance of bitcoin. MSIM is the first U.S. bank-affiliated asset manager to offer a cryptocurrency ETP, and reflects a continued, firmwide focus by Morgan Stanley to develop digital asset solutions designed to meet evolving client demand. "We are proud to introduce MSBT to the marketplace and believe this new ETP aligns with long-term trends in financial innovation and serves to strengthen the range of investments we provide investors," said Ben Huneke, Head of Morgan Stanley Investment Management. "MSBT is an ex

    4/8/26 8:25:00 AM ET
    $MS
    Investment Bankers/Brokers/Service
    Finance

    Tapestry, Inc. Appoints Matt Madrigal to Board of Directors

    Tapestry, Inc. (NYSE:TPR), a house of iconic accessories and lifestyle brands, today announced that Matt Madrigal, Chief Technology Officer of Pinterest, Inc. (NYSE:PINS), has been appointed to the Company's Board of Directors effective immediately. The appointment of Mr. Madrigal brings the Board's membership to eleven, including ten independent directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260406718798/en/Matt Madrigal "We are pleased to welcome Matt to Tapestry's Board. His expertise across technology and customer experience at scale will be instrumental in driving our Amplify growth agenda," said Joanne Crevoiser

    4/6/26 4:15:00 PM ET
    $PINS
    $TPR
    Computer Software: Programming Data Processing
    Technology
    Apparel
    Consumer Discretionary

    XORTX Announces Results of Annual and Special Meeting of Shareholders

    CALGARY, Alberta, March 26, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU)), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease, is pleased to announce the results of its annual and special meeting of shareholders (the "Meeting") held Tuesday, March 24, 2026. A total of 2,407,148 common shares of the Company were represented at the Meeting, representing approximately 35% of the total number of common shares of the Company issued and outstanding. All matters presented for approval at the Meeting were duly authorized and approved including

    3/26/26 6:00:00 PM ET
    $XRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care